Mirum Pharmaceuticals Statistics
Total Valuation
MIRM has a market cap or net worth of $1.99 billion. The enterprise value is $2.03 billion.
Important Dates
The last earnings date was Tuesday, November 12, 2024, before market open.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
MIRM has 48.00 million shares outstanding. The number of shares has increased by 22.57% in one year.
Current Share Class | 48.00M |
Shares Outstanding | 48.00M |
Shares Change (YoY) | +22.57% |
Shares Change (QoQ) | +1.16% |
Owned by Insiders (%) | 1.74% |
Owned by Institutions (%) | 93.99% |
Float | 37.53M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 6.37 |
Forward PS | 4.85 |
PB Ratio | 8.58 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 6.60 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.34, with a Debt / Equity ratio of 1.37.
Current Ratio | 3.34 |
Quick Ratio | 3.05 |
Debt / Equity | 1.37 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -6.71 |
Financial Efficiency
Return on equity (ROE) is -39.84% and return on invested capital (ROIC) is -10.65%.
Return on Equity (ROE) | -39.84% |
Return on Assets (ROA) | -9.10% |
Return on Capital (ROIC) | -10.65% |
Revenue Per Employee | $1.16M |
Profits Per Employee | -$378,072 |
Employee Count | 264 |
Asset Turnover | 0.47 |
Inventory Turnover | 3.83 |
Taxes
In the past 12 months, MIRM has paid $1.83 million in taxes.
Income Tax | 1.83M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +31.49% in the last 52 weeks. The beta is 0.96, so MIRM's price volatility has been similar to the market average.
Beta (5Y) | 0.96 |
52-Week Price Change | +31.49% |
50-Day Moving Average | 42.05 |
200-Day Moving Average | 35.10 |
Relative Strength Index (RSI) | 43.17 |
Average Volume (20 Days) | 418,046 |
Short Selling Information
The latest short interest is 6.72 million, so 13.99% of the outstanding shares have been sold short.
Short Interest | 6.72M |
Short Previous Month | 6.97M |
Short % of Shares Out | 13.99% |
Short % of Float | 17.90% |
Short Ratio (days to cover) | 16.54 |
Income Statement
In the last 12 months, MIRM had revenue of $307.03 million and -$99.81 million in losses. Loss per share was -$2.12.
Revenue | 307.03M |
Gross Profit | 223.15M |
Operating Income | -95.97M |
Pretax Income | -107.43M |
Net Income | -99.81M |
EBITDA | -72.90M |
EBIT | -95.97M |
Loss Per Share | -$2.12 |
Full Income Statement Balance Sheet
The company has $284.45 million in cash and $317.65 million in debt, giving a net cash position of -$33.21 million or -$0.69 per share.
Cash & Cash Equivalents | 284.45M |
Total Debt | 317.65M |
Net Cash | -33.21M |
Net Cash Per Share | -$0.69 |
Equity (Book Value) | 232.02M |
Book Value Per Share | 4.84 |
Working Capital | 270.88M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$1.23 million and capital expenditures -$973,000, giving a free cash flow of -$2.20 million.
Operating Cash Flow | -1.23M |
Capital Expenditures | -973,000 |
Free Cash Flow | -2.20M |
FCF Per Share | -$0.05 |
Full Cash Flow Statement Margins
Gross margin is 72.68%, with operating and profit margins of -31.26% and -32.51%.
Gross Margin | 72.68% |
Operating Margin | -31.26% |
Pretax Margin | -31.91% |
Profit Margin | -32.51% |
EBITDA Margin | -23.74% |
EBIT Margin | -31.26% |
FCF Margin | n/a |
Dividends & Yields
MIRM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -22.57% |
Shareholder Yield | -22.57% |
Earnings Yield | -5.01% |
FCF Yield | -0.11% |
Dividend Details Analyst Forecast
The average price target for MIRM is $57.58, which is 38.71% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $57.58 |
Price Target Difference | 38.71% |
Analyst Consensus | Strong Buy |
Analyst Count | 12 |
Revenue Growth Forecast (5Y) | 35.70% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
MIRM has an Altman Z-Score of 1.17 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.17 |
Piotroski F-Score | 2 |